References
1. D’Agostino RS, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons adult cardiac surgery database: 2017 update on outcomes and quality. Ann Thorac Surg 2017;103:18-24.
2. Gammie JS, Zhao Y, Peterson ED, O’Brien SM, Rankin JS, Griffith BP. Less-invasive mitral valve operations: trends and outcomes from The Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2010;90: 1401-10.
3. Smit Y, Vlayen J, Koppenaal H, et al. Percutaneous coronary invervention versus coronary artery bypass grafting: a meta-analysis. J Thorac Cardiovasc Surg 2015;149:831-8.e1-13.
4. Park SJ, Ahn JM, Kim YH, et al. Trial of everolimuseluting stents or bypass surgery for coronary disease. N Engl J Med 2015;372:1204-12.
5. Sipahi I, Akay MH, Dagdelen S, et al. Coronary artery bypass grafting versus percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: Meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Intern Med 2014;174:223-30.
6. Hannan EL, Zhong Y, Walford G, et al. Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease. J Am Coll Cardiol 2014;64:2717-26.
7. Hayward PA, Buxton BF. Contemporary coronary graft patency: 5-year observational data from a randomized trial of conduits. Ann Thorac Surg 2007;84:795-9.
8. Byrne JG, Leacche M, Vaughan DE, Zhao DX, Hybrid cardiovascular procedures, JACC Cardiovasc Interv, 2008;1(5):459–68.
9. Umakanthan R, Leacche M, Zhao DX, et al., Hybrid options for treating cardiac disease, Semin Thorac Cardiovasc Surg, 2011;23(4):274–80.
10. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323.
11. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA2004;291:1720-29.
12. Moscarelli M, Fattouch K, Casula R, et al. What is the role of minimally invasive mitral valve surgery in highrisk patients? A meta-analysis of observational studies. Ann Thorac Surg 2016;101:981-89.
13. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-52.
14. Kumar AB, Suneja M, Bayman EO, et al. Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: a meta-analysis. J Cardiothorac Vasc Anesth 2012;26:64-9.
15. Cruden NL, Morch K, Wong DR, Klinke WP, Ofiesh J, Hilton JD. Clopidogrel loading dose and bleeding outcomes in patients undergoing urgent coronary artery bypass grafting. Am Heart J 2011;161:404–10.
16. Byrne JG, Leacche M, Unic D, Rawn JD, Simon DI, Rogers CD, et al. Staged initial percutaneous coronary intervention followed by valve surgery (“hybrid approach”) for patients with complex coronary and valve disease. J Am Coll Cardiol. 2005;45:14-8.
17. Brinster DR, Byrne M, Rogers CD, Baim DS, Simon DI, Couper GS, et al. Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease (“hybrid approach”). Am J Cardiol. 2006;98:1501-3.
18. Santana O, Pineda AM, Cortes-Bergoderi M, et al. Hybrid approach of percutaneous coronary intervention followed by minimally invasive valve operations. Ann Thorac Surg 2014;97:2049-55.
19. Mihos CG, Xydas S, Williams RF, Pineda AM, Yucel E, Davila H, Beohar N, Santana O. Staged percutaneous coronary intervention followed by minimally invasive mitral valve surgery versus combined coronary artery bypass graft and mitral valve surgery for two-vessel coronary artery disease and moderate to severe ischemic mitral regurgitation. J Thorac Dis 2017;9(Suppl 7):S563-S568. doi: 10.21037/jtd.2017.04.17.
20. Salis S, Mazzanti VV, Merli G, et al. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth 2008;22:814-22.
21. George I, Nazif TM, Kalesan B, et al. Feasibility and early safety of single-stage hybrid coronary intervention and valvular cardiac surgery. Ann Thorac Surg 2015;99:2032-7.
22. Ranucci M, Ballotta A, Agnelli B, Frigiola A, Menicanti L, Castelvecchio S; Surgical and Clinical Outcome Research (SCORE) Group. Acute kidney injury in patients undergoing cardiac operation and coronary angiography on the same day. Ann Thorac Surg 2013;95:513–9.
23. Kramer RS, Quinn RD, Groom RC, et al; Northern New England Cardiovascular Disease Study Group. Same admission cardiac catheterization and cardiac operation: is there an increased incidence of acute kidney injury? Ann Thorac Surg 2010;90:1418–24.
24. Santana O, Funk M, Zamora C, et al. Staged percutaneous coronary intervention and minimally invasive valve surgery: results of a hybrid approach to concomitant coronary and valvular disease. J Thorac Cardiovasc Surg 2012;144:634-9.
25. Umakanthan R, Leacche M, Petracek MR, et al., Combined PCI and minimally invasive heart valve surgery for high-risk patients, Curr Treat Options Cardiovasc Med, 2009;11(6):492–8.
26. Solenkova NV, Umakanthan R, Leacche M, et al., The new era of cardiac surgery: hybrid therapy for cardiovascular disease, Innovations (Phila), 2010;5(6):388–93.
27. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel and/or left main coronary disease: 5-year follow-up of the randomized, clinical SYNTAX trial. Lancet 2013;381:629–38.
28. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012;367:2375–84.
29. Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits of 15 years. Ann Thorac Surg 2004;77:93–101.
30. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005;111: 3435–3442.